5-Methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile

Names
Preferred IUPAC name 5-Methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile
Other names ROY
Identifiers
CAS Number	138564-59-7 Y
3D model ( JSmol)	Interactive image
ChEMBL	ChEMBL1990114 Y
ChemSpider	350550 Y
ECHA InfoCard	100.101.989
PubChem CID	395460
UNII	J7X181M78Y Y
CompTox Dashboard ( EPA)	DTXSID40160713
InChI InChI=1S/C12H9N3O2S/c1-8-6-9(7-13)12(18-8)14-10-4-2-3-5-11(10)15(16)17/h2-6,14H,1H3 Y Key: NPXUFPFFHANGDL-UHFFFAOYSA-N Y
SMILES Cc1cc(c(s1)Nc2ccccc2[N+](=O)[O-])C#N
Properties [1]
Chemical formula	C12H9N3O2S
Molar mass	259.28 g·mol−1
Melting point	99–102 °C (210–216 °F; 372–375 K)
Hazards
GHS labelling: [2]
Pictograms
Signal word	Warning
Hazard statements	H410
Precautionary statements	P273, P391, P501
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references

5-Methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile, also known as ROY (red-orange-yellow), is an organic compound which is a chemical intermediate to the drug olanzapine. It has been the subject of intensive study because it can exist in multiple well-characterised crystalline polymorphic forms. ^{[3] [4] [5] [6]}

Synthesis

The preparation of ROY was first disclosed in a series of patents from Eli Lilly & Co. in the 1990s, which covered the pharmaceutical active ingredient later marketed as olanzapine. In the first step, a Gewald reaction using propionaldehyde, sulfur and malononitrile formed the thiophene ring system, as 2-amino-5-methylthiophene-3-carbonitrile. The amino group was then reacted with 2-fluoro-nitrobenzene in tetrahydrofuran to provide 5-methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile. ^[1]

Polymorphism

ROY has been crystallised in at least thirteen polymorphic forms. ^{[7] [8]} Five of them, including red, orange and yellow examples are shown in Figure 1.

When this ability to form multiple crystalline versions of different colours was reviewed in 2010, it was described as "extraordinary", particularly because many alternatives can crystallise simultaneously from a single solvent. As the thermodynamic properties of the various versions have been established, ROY has become an important test of computational models. ^[4] By 2020, ROY held the record for having the largest number of well-characterised polymorphs, with its nearest competitors being aripiprazole and galunisertib. ^{[9] [10] [11]} The various crystal forms display alternative conformers, a type of stereoisomerism where rotation at single bonds leads to a distinct three-dimensional configuration in the solid. ^[12] The molecule is piezochromic, with yellow and pale orange crystalline forms which transform reversibly to red at high pressure. ^[8]

In 2022, it was suggested that all the ROY polymorphs which are stable at ambient pressure have already been found and characterised. This work also calculated that additional polymorphs might be discovered using high pressures of about 10 GPa. ^[11]

References